SOURCE: Equity News Circuit
NEW YORK, NY--(Marketwire - Nov 5, 2012) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
Columbia Laboratories Inc. (NASDAQ: CBRX) shares fell 40 percent last Friday after it was reported the FDA declined Watson Pharmaceuticals formal dispute-resolution request, which was filed in August, related to its New Drug Application for Prochieve.
Find out more about Columbia Laboratories including full access to the free equity report at: www.BedfordReport.com/CBRX
Galena Biopharma Inc. (NASDAQ: GALE) recently reported that it has presented positive results from the Phase 1/2 clinical trial of NeuVax at the 27th Annual Meeting of the Society for Immunotherapy of Cancer. Shares of the company have soared nearly 20 percent in the last month.
Find out more about Galena Biopharma including full access to the free equity report at: www.BedfordReport.com/GALE
TASER International, Inc. (NASDAQ: TASR) is engaged in development, manufacture and sale of electronic control devices. Shares of the company soared over 25 percent after reporting an 18 percent rise in third quarter sales, which were boosted by a trade-in program for law-enforcement agencies.
Find out more about TASER International including full access to the free equity report at: www.BedfordReport.com/TASR
Vringo, Inc. (NYSE: VRNG) shares of the mobile software company have soared over 180 percent year-to-date. The company has recently filed a patent infringement lawsuit against the UK subsidiary of ZTE Corporation.
Find out more about Vringo including full access to the free equity report at: www.BedfordReport.com/VRNG
Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com, has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, have a financial relationship with any company whose stock is mentioned in this release.